查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2022801

全球精密医疗设备市场：市场规模、份额和趋势分析（按器材类型、技术、应用、最终用户和连接方式划分）—市场机会分析和产业预测（2026-2036 年）

Precision Medical Devices Market Size, Share & Trends Analysis by Device Type (Diagnostic Devices, Monitoring Devices), Technology, Application, End User, and Connectivity - Global Opportunity Analysis & Industry Forecast (2026-2036)
出版日期: | 出版商: Meticulous Research | 英文 310 Pages | 商品交期: 5-7个工作天内

价格
简介目录

全球精准医疗设备市场预计将从2026年的537亿美元成长至2036年的984亿美元，预测期间（2026-2036年）复合年增长率（CAGR）为6.2%。这项市场成长主要受多种结构性因素驱动，包括全球精准医疗的模式转移，以及人工智慧、机器人和先进感测器等技术加速融入临床设备平台。精准医疗透过基因组学、蛋白质组学和生理学数据，针对个别患者特征优化临床干预，其在全球范围内的普及从根本上重塑了对医疗设备的需求，要求诊断系统能够在分子水平上对疾病进行表征，医疗设备能够以前所未有的解剖学精度提供个性化治疗。

随着医疗产业从被动的标准化模式转向预防性的个人化干预，全球精准医疗设备市场正经历根本性的结构性变革。这项变革的驱动力在于高解析度资料流和先进分析技术的融合，使医疗设备从被动的工具转变为临床照护中积极主动的智慧伙伴。产业正朝着互联生态系统发生重大转变，穿戴式感测器和远端监测平台能够提供持续、长期的患者健康洞察，取代碎片化的治疗方案。此外，机器人辅助手术和影像引导介入技术的快速发展正在重新定义手术精确度，使微创手术能够达到亚毫米级的精确度。这种动态变化正在推动对人工智慧驱动的诊断平台和个人化植入式医疗设备的需求持续成长。这些设备将帮助临床医生实现更高的诊断准确率和治疗效果，最终改善各种急性疾病患者的治疗效果。

目录

第一章：引言

第二章 分析方法

第三章执行摘要

第四章 市场概览

  • 市场动态
    • 促进因素
      • 精准医疗和个人化医疗的广泛应用
      • 对微创手术的需求日益增长
      • 影像、机器人和感测器技术的进步
      • 慢性病盛行率增加
    • 抑制因子
      • 先进精密设备高成本
      • 复杂的监管核准流程
      • 与医疗资讯系统整合面临的挑战
    • 机会
      • 穿戴式和远端监控设备的成长
      • 人工智慧诊断设备的扩展
      • 新兴市场采用率的扩大
      • 开发个人化植入式设备
    • 任务
      • 数据准确性和互通性问题
      • 连网型设备的网路安全风险
  • 科技趋势
    • 人工智慧和机器学习在医疗设备的应用
    • 机器人手术与电脑辅助手术
    • 先进的成像技术
    • 生物感测器和可穿戴技术
    • 3D列印和个人化植入
  • 价值链分析
    • 组件供应商（感测器、晶片、材料）
    • 设备製造商
    • 软体和人工智慧平台提供商
    • 医疗服务提供方
    • 患者和最终用户
  • 法规和标准的发展趋势
    • FDA医疗设备法规
    • 欧盟医疗器材法规和CE标誌
    • ISO标准（ISO 13485、IEC 60601）
    • 资料隐私法规（HIPAA、GDPR）
  • 波特五力分析

第五章：精密医疗设备市场：依器材类型划分（主要细分市场）

  • 诊断设备
    • 诊断影像系统（MRI、CT、超音波）
    • 分子和基因组诊断设备
    • 即时诊断设备
  • 用于治疗的医疗设备
    • 雷射治疗设备
    • 放射治疗设备
    • 药物输送系统
  • 监控设备
    • 持续血糖监测（CGM）
    • 心臟监测设备
    • 远端患者监护系统
    • 穿戴式健康设备
  • 外科和介入医疗设备
    • 机器人手术系统
    • 影像导引手术设备
    • 微创手术器械
  • 植入式医疗设备
    • 心臟植入（心律调节器、ICD）
    • 整形外科植入
    • 神经刺激装置
    • 个性化/3D列印植入
  • 其他精密医疗设备

第六章：精准医疗设备市场：依技术划分

  • 人工智慧和机器学习
  • 机器人与自动化
  • 感测器和生物感测器技术
  • 成像技术
  • 3D列印与积层製造

第七章：精密医疗设备市场：依应用领域划分

  • 循环系统疾病
  • 瘤
  • 神经系统疾病
  • 整形外科
  • 糖尿病管理
  • 呼吸护理
  • 其他的

第八章：精准医疗设备市场：依最终用户划分

  • 医院和诊所
  • 门诊手术中心
  • 诊断检查室
  • 居家医疗
  • 研究和学术机构

第九章：精密医疗设备市场：精准度等级（详细分类）

  • 标准精密医疗设备
  • 高精度医疗设备
  • 超高精度/客製化设备

第十章：精密医疗设备市场：依连接方式划分

  • 独立设备
  • 联网/物联网设备
  • 云端连线装置

第十一章：精准医疗设备市场：依地区划分

  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 瑞士
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 新加坡
    • 泰国
    • 马来西亚
    • 印尼
    • 越南
    • 其他亚太国家
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 智利
    • 哥伦比亚
    • 其他拉丁美洲国家
  • 中东和非洲
    • UAE
    • 沙乌地阿拉伯
    • 南非
    • 土耳其
    • 以色列
    • 其他中东和非洲国家

第十二章 竞争格局

  • 关键成长策略
  • 竞争性标竿分析
  • 竞争对手仪錶板
    • 产业领导者
    • 市场差异化因素
    • 先锋公司
    • 新兴企业
  • 主要企业市场排名和定位分析（2025 年）

第十三章：公司简介

  • Medtronic plc
  • Siemens Healthineers AG
  • GE HealthCare Technologies Inc.
  • Philips Healthcare
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Stryker Corporation
  • Intuitive Surgical, Inc.
  • Johnson & Johnson（MedTech）
  • Becton, Dickinson and Company（BD）
  • Roche Diagnostics
  • Dexcom, Inc.
  • Zimmer Biomet Holdings
  • ResMed Inc.
  • Masimo Corporation

第十四章附录

简介目录
Product Code: MRHC - 1041890

Precision Medical Devices Market Size, Share & Trends Analysis by Device Type (Diagnostic Devices, Monitoring Devices, Therapeutic Devices, Surgical Devices, Implantable Devices), Technology (AI, Robotics, Sensors, 3D Printing), Application, End User, and Connectivity - Global Opportunity Analysis & Industry Forecast (2026-2036)

According to the research report titled, 'Precision Medical Devices Market Size, Share, and Trends Analysis by Device Type (Diagnostic Devices, Monitoring Devices, Therapeutic Devices, Surgical & Interventional Devices, Implantable Devices), Technology (AI & ML, Robotics & Automation, Sensor & Biosensor, Imaging, 3D Printing), Application (Cardiology, Oncology, Neurology, Orthopedics, Diabetes Management, Respiratory Care), End User (Hospitals & Clinics, ASCs, Diagnostic Labs, Home Healthcare, Research Institutes), Connectivity (Standalone, Connected/IoT, Cloud-Integrated), and Geography-Global Forecast to 2036,' the global precision medical devices market is projected to reach USD 98.4 billion by 2036 from USD 53.7 billion in 2026, growing at a CAGR of 6.2% during the forecast period (2026-2036). The growth of this market is primarily driven by the converging structural forces of the global precision medicine paradigm shift and the accelerating technology integration of artificial intelligence, robotics, and advanced sensors into clinical device platforms. The global adoption of precision medicine-which tailors clinical interventions to individual patient characteristics defined by genomic, proteomic, and physiological data-is fundamentally reshaping requirements for medical devices, demanding diagnostic systems capable of molecular-level disease characterization and therapeutic devices capable of delivering individualized treatment at anatomical precision levels previously unattainable.

The global precision medical devices market is undergoing a profound structural transformation as the healthcare industry moves from a reactive, one-size-fits-all model toward proactive, personalized interventions. This evolution is being catalyzed by the integration of high-resolution data streams with advanced analytics, enabling devices to transition from passive tools to active, intelligent partners in clinical care. The industry is witnessing a significant shift toward connected ecosystems where wearable sensors and remote monitoring platforms provide a continuous longitudinal view of patient health, replacing episodic clinical encounters. Furthermore, the rapid advancement of robotic-assisted surgery and image-guided interventions is redefining surgical precision, allowing for minimally invasive procedures with sub-millimeter accuracy. This dynamic shift ensures sustained demand for AI-enabled diagnostic platforms and personalized implantable devices that empower clinicians to achieve higher levels of diagnostic accuracy and therapeutic efficacy, ultimately improving patient outcomes across a wide range of chronic and acute conditions.

Market Segmentation

The global precision medical devices market is segmented by device type (diagnostic devices, monitoring devices, therapeutic devices, surgical & interventional devices, and implantable devices), technology (AI & ML, robotics & automation, sensor & biosensor technologies, imaging technologies, and 3D printing), application (cardiology, oncology, neurology, orthopedics, diabetes management, respiratory care, and others), end user (hospitals & clinics, ambulatory surgical centers, diagnostic laboratories, home healthcare settings, and research & academic institutes), connectivity (standalone, connected/IoT-enabled, and cloud-integrated), and geography. The study evaluation includes industry competitors and analyzes the market at the country level.

Based on Device Type

By device type, the diagnostic devices segment is expected to hold the largest share of the global precision medical devices market in 2026. This segment includes high-value imaging systems, molecular diagnostics, and point-of-care devices that are essential for early disease detection and characterization. Conversely, the monitoring devices segment, particularly wearable and remote patient monitoring systems, is projected to register the highest CAGR during the forecast period. This rapid growth is driven by the post-pandemic expansion of telehealth and the increasing demand for continuous physiological monitoring in chronic disease management. Surgical and interventional devices, including robotic platforms, also represent a significant and fast-growing segment as hospitals invest in technology to improve procedural precision and patient recovery times.

Based on Technology

By technology, the imaging technologies segment is expected to hold the largest share of the market in 2026. Advanced imaging remains the cornerstone of precision diagnostics, providing the anatomical and functional detail required for personalized treatment planning. However, the artificial intelligence and machine learning segment is projected to register the highest CAGR. AI is increasingly being integrated into diagnostic platforms to automate image interpretation, detect subtle pathologies, and provide predictive clinical decision support. Sensor and biosensor technologies are also witnessing rapid adoption, enabling the miniaturization of precision monitoring devices for home and wearable use.

Based on End User

By end user, the hospitals and clinics segment is expected to hold the largest share in 2026. The dominance of this sector is underpinned by the concentration of advanced diagnostic and surgical infrastructure in centralized healthcare facilities. Conversely, the home healthcare settings segment is projected to register the highest CAGR during the forecast period. This shift is fueled by the democratization of precision monitoring through smartphone-connected devices and the clinical trend toward decentralized care delivery. Ambulatory Surgical Centers (ASCs) also represent a growing segment, as they increasingly adopt precision surgical and interventional tools to offer cost-effective, high-quality outpatient procedures.

Geographic Analysis

In 2026, North America is expected to account for the largest share of the global precision medical devices market. The region's leadership is driven by the United States' position as the world's largest medical device market, supported by the presence of leading global corporations such as Medtronic, Abbott, and GE HealthCare. The region benefits from a robust reimbursement environment for advanced technologies and a highly sophisticated regulatory ecosystem administered by the FDA. Furthermore, the high level of healthcare expenditure and the rapid adoption of AI and robotic technologies in clinical settings further solidify North America's dominant market position.

Asia-Pacific is projected to witness the fastest growth during the forecast period. This rapid expansion is primarily driven by the rapidly expanding healthcare infrastructure across China, India, and Southeast Asia. The region's large and aging population is generating sustained demand for precision diagnostic and monitoring devices to manage chronic conditions. Furthermore, government initiatives to modernize healthcare systems and the growing domestic manufacturing base for medical devices are creating significant opportunities for both local and international players. Key regional hubs like Japan and South Korea remain at the forefront of robotic and imaging technology adoption.

Europe represents a significant market for precision medical devices, characterized by a strong emphasis on clinical research and high-quality healthcare delivery. Germany, the U.K., and France are the key regional hubs, hosting world-class medical institutions and material science leaders. The region is seeing increased adoption of connected health technologies and precision surgical tools, supported by evolving regulatory frameworks such as the EU MDR. Key companies in the European market include Siemens Healthineers (Germany) and Philips Healthcare (Netherlands).

Latin America and the Middle East & Africa are emerging markets for precision medical devices. In the MEA region, Israel and the UAE are significant demand centers for advanced diagnostic and robotic technologies. Latin America is seeing growing investment in healthcare infrastructure and a rising focus on managing the growing burden of non-communicable diseases through improved diagnostic and monitoring capabilities.

Key Players

The key players operating in the global precision medical devices market include Medtronic plc (Ireland), Siemens Healthineers AG (Germany), GE HealthCare Technologies Inc. (U.S.), Philips Healthcare (Netherlands), Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), Stryker Corporation (U.S.), Intuitive Surgical, Inc. (U.S.), Johnson & Johnson (MedTech) (U.S.), Becton, Dickinson and Company (BD) (U.S.), Roche Diagnostics (Switzerland), Dexcom, Inc. (U.S.), Zimmer Biomet Holdings (U.S.), ResMed Inc. (U.S.), and Masimo Corporation (U.S.).

Key Questions Answered in the Report-

  • What is the value of revenue generated from the global precision medical devices market?
  • At what rate is the precision medical devices demand projected to grow for the next 10 years?
  • What are the historical market sizes and growth rates of the global precision medical devices market?
  • What are the major factors impacting the growth of this market? What are the major opportunities for existing players and new entrants in the market?
  • Which segments in terms of device type, technology, application, end user, and connectivity are expected to create major traction for the vendors in this market?
  • What are the key geographical trends in this market? Which regions/countries are expected to offer significant growth opportunities for the companies operating in the precision medical devices market?
  • Who are the major players in the precision medical devices market? What are their specific offerings in this market?
  • What are the recent strategic developments in the global precision medical devices market? What are the impacts of these strategic developments on the market?

Scope of the Report:

Precision Medical Devices Market Assessment -- by Device Type

  • Diagnostic Devices (Imaging Systems, Molecular & Genomic Diagnostics, Point-of-Care Diagnostics)
  • Monitoring Devices (Continuous Glucose Monitors, Cardiac Monitors, Remote Patient Monitoring, Wearable Health Devices)
  • Therapeutic Devices ( Laser-Based Treatment, Radiation Therapy, Drug Delivery Systems)
  • Surgical & Interventional Devices (Robotic Surgical Systems, Image-Guided Surgical Devices, Minimally Invasive Instruments)
  • Implantable Devices (Cardiac Implants, Orthopedic Implants, Neurostimulation Devices, Personalized/3D-Printed Implants)

Precision Medical Devices Market Assessment -- by Technology

  • Artificial Intelligence & Machine Learning
  • Robotics & Automation
  • Sensor & Biosensor Technologies
  • Imaging Technologies
  • 3D Printing & Additive Manufacturing

Precision Medical Devices Market Assessment -- by Application

  • Cardiology
  • Oncology
  • Neurology
  • Orthopedics
  • Diabetes Management
  • Respiratory Care
  • Others

Precision Medical Devices Market Assessment -- by End User

  • Hospitals & Clinics
  • Ambulatory Surgical Centers (ASCs)
  • Diagnostic Laboratories
  • Home Healthcare Settings
  • Research & Academic Institutes

Precision Medical Devices Market Assessment -- by Connectivity

  • Standalone Devices
  • Connected / IoT-Enabled Devices
  • Cloud-Integrated Devices

Precision Medical Devices Market Assessment -- by Geography

  • North America (U.S., Canada)
  • Europe (Germany, U.K., France, Italy, Spain, Netherlands, Sweden, Switzerland, Rest of Europe)
  • Asia-Pacific (China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Vietnam, Rest of Asia-Pacific)
  • Latin America (Brazil, Mexico, Argentina, Chile, Colombia, Rest of Latin America)
  • Middle East & Africa (UAE, Saudi Arabia, South Africa, Turkey, Israel, Rest of MEA)

TABLE OF CONTENTS

1. Introduction

  • 1.1 Market Definition
  • 1.2 Market Ecosystem
  • 1.3 Currency and Limitations
    • 1.3.1 Currency
    • 1.3.2 Limitations
  • 1.4 Key Stakeholders

2. Research Methodology

  • 2.1 Research Approach
  • 2.2 Data Collection & Validation Process
    • 2.2.1 Secondary Research
    • 2.2.2 Primary Research & Validation
      • 2.2.2.1 Primary Interviews with Experts
      • 2.2.2.2 Approaches for Country-/Region-Level Analysis
  • 2.3 Market Estimation
    • 2.3.1 Bottom-Up Approach
    • 2.3.2 Top-Down Approach
    • 2.3.3 Growth Forecast
  • 2.4 Data Triangulation
  • 2.5 Assumptions for the Study

3. Executive Summary

4. Market Overview

  • 4.1 Introduction
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
      • 4.2.1.1 Growing Adoption of Precision Medicine and Personalized Healthcare
      • 4.2.1.2 Increasing Demand for Minimally Invasive Procedures
      • 4.2.1.3 Advancements in Imaging, Robotics, and Sensor Technologies
      • 4.2.1.4 Rising Prevalence of Chronic Diseases
    • 4.2.2 Restraints
      • 4.2.2.1 High Cost of Advanced Precision Devices
      • 4.2.2.2 Complex Regulatory Approval Processes
      • 4.2.2.3 Integration Challenges with Healthcare IT Systems
    • 4.2.3 Opportunities
      • 4.2.3.1 Growth in Wearable and Remote Monitoring Devices
      • 4.2.3.2 Expansion of AI-Enabled Diagnostic Devices
      • 4.2.3.3 Increasing Adoption in Emerging Markets
      • 4.2.3.4 Development of Personalized Implantable Devices
    • 4.2.4 Challenges
      • 4.2.4.1 Data Accuracy and Interoperability Issues
      • 4.2.4.2 Cybersecurity Risks in Connected Devices
  • 4.3 Technology Landscape
    • 4.3.1 AI and Machine Learning in Medical Devices
    • 4.3.2 Robotics and Computer-Assisted Surgery
    • 4.3.3 Advanced Imaging Technologies
    • 4.3.4 Biosensors and Wearable Technologies
    • 4.3.5 3D Printing and Personalized Implants
  • 4.5 Value Chain Analysis
    • 4.5.1 Component Suppliers (Sensors, Chips, Materials)
    • 4.5.2 Device Manufacturers
    • 4.5.3 Software & AI Platform Providers
    • 4.5.4 Healthcare Providers
    • 4.5.5 Patients & End Users
  • 4.6 Regulatory and Standards Landscape
    • 4.6.1 FDA Medical Device Regulations
    • 4.6.2 EU MDR and CE Marking
    • 4.6.3 ISO Standards (ISO 13485, IEC 60601)
    • 4.6.4 Data Privacy Regulations (HIPAA, GDPR)
  • 4.7 Porter's Five Forces Analysis

5. Precision Medical Devices Market, by Device Type (Primary Segmentation)

  • 5.1 Introduction
  • 5.2 Diagnostic Devices
    • 5.2.1 Imaging Systems (MRI, CT, Ultrasound)
    • 5.2.2 Molecular & Genomic Diagnostic Devices
    • 5.2.3 Point-of-Care Diagnostic Devices
  • 5.3 Therapeutic Devices
    • 5.3.1 Laser-Based Treatment Devices
    • 5.3.2 Radiation Therapy Devices
    • 5.3.3 Drug Delivery Systems
  • 5.4 Monitoring Devices
    • 5.4.1 Continuous Glucose Monitors (CGM)
    • 5.4.2 Cardiac Monitoring Devices
    • 5.4.3 Remote Patient Monitoring Systems
    • 5.4.4 Wearable Health Devices
  • 5.5 Surgical & Interventional Devices
    • 5.5.1 Robotic Surgical Systems
    • 5.5.2 Image-Guided Surgical Devices
    • 5.5.3 Minimally Invasive Surgical Instruments
  • 5.6 Implantable Devices
    • 5.6.1 Cardiac Implants (Pacemakers, ICDs)
    • 5.6.2 Orthopedic Implants
    • 5.6.3 Neurostimulation Devices
    • 5.6.4 Personalized/3D-Printed Implants
  • 5.7 Other Precision Medical Devices

6. Precision Medical Devices Market, by Technology

  • 6.1 Introduction
  • 6.2 Artificial Intelligence & Machine Learning
  • 6.3 Robotics & Automation
  • 6.4 Sensor & Biosensor Technologies
  • 6.5 Imaging Technologies
  • 6.6 3D Printing & Additive Manufacturing

7. Precision Medical Devices Market, by Application

  • 7.1 Introduction
  • 7.2 Cardiology
  • 7.3 Oncology
  • 7.4 Neurology
  • 7.5 Orthopedics
  • 7.6 Diabetes Management
  • 7.7 Respiratory Care
  • 7.8 Others

8. Precision Medical Devices Market, by End User

  • 8.1 Introduction
  • 8.2 Hospitals & Clinics
  • 8.3 Ambulatory Surgical Centers
  • 8.4 Diagnostic Laboratories
  • 8.5 Home Healthcare Settings
  • 8.6 Research & Academic Institutes

9. Precision Medical Devices Market, by Precision Level (Advanced Segmentation)

  • 9.1 Introduction
  • 9.2 Standard Precision Devices
  • 9.3 High-Precision Devices
  • 9.4 Ultra-Precision / Personalized Devices

10. Precision Medical Devices Market, by Connectivity

  • 10.1 Introduction
  • 10.2 Standalone Devices
  • 10.3 Connected / IoT-Enabled Devices
  • 10.4 Cloud-Integrated Devices

11. Precision Medical Devices Market, by Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 U.S.
    • 11.2.2 Canada
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 U.K.
    • 11.3.3 France
    • 11.3.4 Italy
    • 11.3.5 Spain
    • 11.3.6 Netherlands
    • 11.3.7 Sweden
    • 11.3.8 Switzerland
    • 11.3.9 Rest of Europe
  • 11.4 Asia-Pacific
    • 11.4.1 China
    • 11.4.2 Japan
    • 11.4.3 India
    • 11.4.4 South Korea
    • 11.4.5 Australia
    • 11.4.6 Singapore
    • 11.4.7 Thailand
    • 11.4.8 Malaysia
    • 11.4.9 Indonesia
    • 11.4.10 Vietnam
    • 11.4.11 Rest of Asia-Pacific
  • 11.5 Latin America
    • 11.5.1 Brazil
    • 11.5.2 Mexico
    • 11.5.3 Argentina
    • 11.5.4 Chile
    • 11.5.5 Colombia
    • 11.5.6 Rest of Latin America
  • 11.6 Middle East & Africa
    • 11.6.1 UAE
    • 11.6.2 Saudi Arabia
    • 11.6.3 South Africa
    • 11.6.4 Turkey
    • 11.6.5 Israel
    • 11.6.6 Rest of Middle East & Africa

12. Competitive Landscape

  • 12.1 Overview
  • 12.2 Key Growth Strategies
  • 12.3 Competitive Benchmarking
  • 12.4 Competitive Dashboard
    • 12.4.1 Industry Leaders
    • 12.4.2 Market Differentiators
    • 12.4.3 Vanguards
    • 12.4.4 Emerging Companies
  • 12.5 Market Ranking/Positioning Analysis of Key Players, 2025

13. Company Profiles

  • 13.1 Medtronic plc
  • 13.2 Siemens Healthineers AG
  • 13.3 GE HealthCare Technologies Inc.
  • 13.4 Philips Healthcare
  • 13.5 Abbott Laboratories
  • 13.6 Boston Scientific Corporation
  • 13.7 Stryker Corporation
  • 13.8 Intuitive Surgical, Inc.
  • 13.9 Johnson & Johnson (MedTech)
  • 13.10 Becton, Dickinson and Company (BD)
  • 13.11 Roche Diagnostics
  • 13.12 Dexcom, Inc.
  • 13.13 Zimmer Biomet Holdings
  • 13.14 ResMed Inc.
  • 13.15 Masimo Corporation

14. Appendix

  • 14.1 Additional Customization
  • 14.2 Related Reports